128 Results

People

  1. Kris
    Kris
  2. Gralla
    Gralla
  3. Kelsen
    Kelsen
  4. Tyson
    Tyson
  5. Hudis
    Hudis
  6. Scher
    Scher
  7. Clark
    Clark
  8. Heelan
    Heelan
  9. Ilson
    Ilson
  10. Bajorin
    Bajorin

Groups

  1. Department of Medicine (80)
  2. Solid Tumor Oncology Division (65)
  3. Survivorship Research (32)
  4. Gastrointestinal Oncology Service (22)
  5. Center for Pancreatic Cancer Research (21)
  6. Nursing (21)
  7. Thoracic Oncology (18)
  8. Genitourinary Oncology Service (15)
  9. Hematologic Malignancies, Division of (15)
  10. Surgery (13)
  1. "diphenhydramine"
Formats
  1. Journal Article (123)
  2. Conference Paper (2)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (80)
  2. Solid Tumor Oncology Division (65)
  3. Survivorship Research (32)
  4. Gastrointestinal Oncology Service (22)
  5. Center for Pancreatic Cancer Research (21)
  6. Nursing (21)

More Groups

People
  1. Mark Kris (18)
  2. Richard Gralla (14)
  3. David Kelsen (10)
  4. Leslie Tyson (9)
  5. Clifford Hudis (8)
  6. Howard Scher (8)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (1)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Cancer (12)
  3. Cancer Treatment Reports (5)
  4. Clinical Cancer Research (5)
  5. Gynecologic Oncology (5)
  6. Cancer Investigation (4)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. American Society of Clinical Oncology (16)
  3. Wiley Blackwell (12)
  4. Lippincott Williams & Wilkins (8)
  5. American Association for Cancer Research (7)
  6. Springer (7)

More Publishers

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Falchi, L.; Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Dickinson, M.; Cartron, G.; Khan, C.; Tani, M.; Martinez-Lopez, J.; Bartlett, N. L.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A phase II study of acimtamig (AFM13) in patients with CD30-positive, relapsed, or refractory peripheral T-cell lymphomas
    Journal Article

    Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhailova, N.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; Emig, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Omalizumab for treatment of anti-GD2 antibody-related urticaria
    Journal Article

    Glincher, R.; Lentini-Rivera, A.; Jones, L. A.; D'Andrea, L.; Durney, C.; Kasper, C.; Lin, Y.; Shrager, L.; Markova, A.; Lacouture, M.; more...
    Journal of Pediatric Hematology/Oncology (2024)

    Fulltext@MSK | Save
  • A quality improvement initiative standardizing premedication for blood product transfusions
    Journal Article

    Shahid, S.; Rosenzweig, J.; Troullioud Lucas, A.; McThenia, S. S.; Fong, C.; Degliuomini, M. D.; Wuest, D.; Kaicker, S.; Slotkin, E. K.
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events
    Review

    Mora, J.; Chan, G. C.; Morgenstern, D. A.; Nysom, K.; Bear, M. K.; Tornøe, K.; Kushner, B. H.
    Cancer Reports (2023)

    Fulltext@MSK | Save
  • Simplified graded infusion strategy for mitigation of oxaliplatin hypersensitivity
    Journal Article

    Alonso Martinez, S.; Segal, N. H.; Cercek, A.; Yaeger, R.; Stadler, Z.; Kemeny, N. E.; Nusrat, M.; Shahrokni, A.; Connell, L.; Saltz, L. B.
    Clinical Colorectal Cancer (2022)

    Fulltext@MSK | Save
  • Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
    Journal Article

    Kyi, C.; Doubrovina, E.; Zhou, Q.; Kravetz, S.; Iasonos, A.; Aghajanian, C.; Sabbatini, P.; Spriggs, D.; O'Reilly, R. J.; O'Cearbhaill, R. E.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Authors' reply to the comment “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa”
    Correspondence

    Ghias, M. H.; Johnston, A. D.; Kutner, A. J.; Micheletti, R. G.; Hosgood, H. D.; Cohen, S. R.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients
    Journal Article

    Thoren, K. L.; Avecilla, S. T.; Klimek, V.; Goss, C.
    Transfusion (2020)

    Fulltext@MSK | Save